Veru (NASDAQ: VERU), an oncology-focused biotech, saw its share price leap by over 20% on Tuesday, crushing not only the top stock market indexes, but also many peers in its sector. The reason why was ...
Veru Inc. (VERU) stock has exhibited solid momentum over the past few weeks owing to the company’s recent clinical study of oral medicine sabizabulin, which reduces fatalities by more than 50% in ...
At its 2026 Annual Meeting of Shareholders held on March 12, 2026, Veru Inc. won investor approval to significantly expand its 2018 Equity Incentive Plan, more than doubling the pool of common shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results